Economic cultivation of medicinal mushrooms: A Comprehensive Review

Introduction

Medicinal mushrooms have been recognized for their nutritional and therapeutic properties for thousands of years and have occupied a prominent place in traditional healthcare systems, particularly in China, Japan, Korea, India, and other Asian countries. Ancient medical texts documented th e use of mushrooms such as Ganoderma lucidum (Reishi), Lentinula edodes (Shiitake), Cordyceps sinensis, and Hericium erinaceus (Lion's Mane) for promoting longevity, enhancing immunity, improving vitality, and treating various chronic diseases. Over the past three decades, scientific research has validated many of these traditional claims by identifying numerous bioactive compounds possessing antioxidant, immunomodulatory, anticancer, antimicrobial, antiviral, anti-inflammatory, hypoglycemic, hepatoprotective, cardioprotective, and neuroprotective activities (Aditya et al., 2025a) [1,2] . The increasing consumer preference for natural products, functional foods, and nutraceuticals has significantly expanded the global medicinal mushroom industry [3] .

Unlike edible mushrooms that are primarily consumed as food, medicinal mushrooms are cultivated specifically for their therapeutic compounds, including polysaccharides, β-glucans, triterpenoids, phenolic compounds, lectins, sterols, proteins, peptides, alkaloids, and terpenes. These secondary metabolites have attracted considerable attention from pharmaceutical companies because of their potential applications in developing novel therapeutic agents against cancer, diabetes, cardiovascular diseases, Alzheimer's disease, Parkinson's disease, obesity, and immune disorders. The economic significance of medicinal mushroom cultivation extends beyond healthcare. Mushroom farming provides an attractive enterprise for small-scale farmers, women entrepreneurs, rural youth, and agribusiness startups due to its relatively low land requirement, short production cycle, efficient utilization of agricultural wastes, and high market value. Cultivation can be carried out using inexpensive lignocellulosic substrates such as wheat straw, rice straw, maize stalks, sugarcane bagasse, sawdust, cotton waste, coffee husks, tea residues, and other agroindustrial by-products, thereby converting agricultural waste into high-value products while supporting environmental sustainability and the circular bioeconomy. Medicinal mushroom cultivation contributes significantly to sustainable agriculture through waste recycling, carbon sequestration, reduced environmental pollution, and the generation of nutrient-rich spent mushroom substrate that can be utilized as organic manure, vermicompost, livestock feed, or biofertilizer. These characteristics make mushroom cultivation an environmentally friendly enterprise aligned with global sustainable development goals. Technological advancements have further enhanced the commercial feasibility of medicinal mushroom production. Controlled environment cultivation, improved spawn production techniques, sterilized substrate preparation, climate-controlled production units, automated humidity and temperature management, molecular breeding, biotechnology, Internet of Things (IoT)-based monitoring systems, artificial intelligenceassisted crop management, and precision mushroom farming have collectively increased biological efficiency, reduced production risks, and improved product quality. Furthermore, advanced extraction techniques have enabled the development of high-value products such as mushroom powders, capsules, tablets, teas, beverages, cosmetics, functional foods, dietary supplements, and pharmaceutical formulations (Aditya and Jarial, 2023) [3][4][5] . Despite remarkable progress, several challenges continue to constrain the expansion of medicinal mushroom cultivation. These include contamination during spawn production, inconsistent substrate quality, inadequate technical knowledge among growers, high initial investment for environmental control systems, post-harvest deterioration, lack of standardized cultivation protocols for several medicinal species, limited processing infrastructure, regulatory constraints, and market fluctuations. Addressing these issues requires multidisciplinary research integrating mycology, biotechnology, agricultural engineering, economics, food technology, and environmental sciences. The present review comprehensively summarizes the current knowledge regarding medicinal mushroom cultivation, including taxonomy, biology, cultivation technologies, substrate selection, environmental requirements, spawn production, harvesting, processing, value addition, medicinal properties, economic feasibility, marketing opportunities, and future research priorities. The review emphasizes economically sustainable cultivation practices that can enhance profitability while promoting environmentally responsible agricultural production systems.

Global Status of Medicinal Mushroom Cultivation

The global mushroom industry has experienced remarkable growth over the last two decades, driven by increasing awareness of health-promoting foods, expanding pharmaceutical applications, and rising consumer demand for natural therapeutics. While edible mushrooms such as button (Agaricus bisporus), oyster (Pleurotus spp.), and paddy straw (Volvariella volvacea) dominate overall production, medicinal mushrooms represent one of the fastestgrowing segments of the global mushroom market because of their superior economic value and expanding applications in nutraceuticals, pharmaceuticals, cosmetics, and functional foods. Asia remains the global leader in medicinal mushroom cultivation, accounting for the majority of worldwide production. China dominates global production and consumption, contributing more than 75% of commercially cultivated medicinal mushrooms. The country has developed highly mechanized cultivation systems, advanced spawn production technologies, and extensive processing industries that produce extracts, capsules, beverages, powders, and medicinal formulations. Japan and South Korea have also established sophisticated medicinal mushroom industries focusing on premium-quality Lentinula edodes, Ganoderma lucidum, Grifola frondosa, and Hericium erinaceus. These countries emphasize scientific cultivation methods, quality assurance, standardized processing, and international marketing. North America and Europe have witnessed rapid growth in medicinal mushroom production due to increasing consumer awareness regarding natural health supplements and functional foods. Commercial cultivation has expanded in the United States, Canada, Germany, France, Italy, the Netherlands, and the United Kingdom. Modern cultivation facilities equipped with climate-controlled systems, automation, and strict quality control produce high-quality medicinal mushrooms for domestic consumption and export markets. Regulatory support for nutraceuticals and functional foods has further accelerated industrial growth. India possesses enormous potential for medicinal mushroom cultivation because of its diverse agroclimatic conditions, abundant agricultural residues, low labor costs, and growing domestic demand. Traditionally, commercial mushroom production in India has focused on button, oyster, and milky mushrooms; however, cultivation of medicinal mushrooms such as Ganoderma lucidum, Cordyceps militaris, Lentinula edodes, and Hericium erinaceus is increasing rapidly through research institutions, private enterprises, and agricultural startups. Organizations, including ICAR, agricultural universities and state horticulture departments, actively promote mushroom entrepreneurship through training programs, financial assistance, and technology dissemination. The global medicinal mushroom market is expected to maintain strong growth due to increasing incidences of chronic diseases, aging populations, consumer preference for preventive healthcare, and expanding applications in pharmaceutical research. Products derived from medicinal mushrooms now include dietary supplements, herbal medicines, functional beverages, protein powders, cosmetic formulations, immune boosters, anti-aging products, sports nutrition supplements, and veterinary health products.

Continuous

investment in biotechnology, genetic improvement, fermentation technologies, and extraction methods is expected to further expand commercial opportunities. Several medicinal mushroom species have emerged as commercially important worldwide. Ganoderma lucidum remains the most valuable medicinal mushroom because of its immunomodulatory and anticancer properties. Lentinula edodes is extensively cultivated for both culinary and medicinal applications due to the presence of lentinan. Hericium erinaceus has gained international popularity for its neuroprotective compounds, while Cordyceps militaris has become an important commercial species for its production of cordycepin. Grifola frondosa, Trametes versicolor, Agaricus blazei and Phellinus linteus have also attracted considerable commercial attention due to their unique pharmacological activities. Government support, increasing research funding, technological innovations, and expanding export markets indicate that medicinal mushroom cultivation will continue to play an increasingly important role in sustainable agriculture, rural development, and the global bioeconomy.

Biology and Classification of Major Medicinal Mushrooms

Medicinal mushrooms comprise a diverse group of macrofungi that produce large fruiting bodies and synthesize biologically active secondary metabolites with significant therapeutic value. Most economically important medicinal mushrooms belong to the phylum Basidiomycota, while a smaller number belong to Ascomycota. These fungi obtain nutrients through saprophytic, parasitic, or symbiotic modes of nutrition and reproduce through microscopic spores that germinate to produce hyphae. Interconnected hyphae form a mycelial network, which colonizes the substrate and ultimately develops into mature fruiting bodies under favourable environmental conditions. The life cycle of medicinal mushrooms begins with spore germination, followed by the formation of monokaryotic mycelium. Fusion of compatible hyphae produces dikaryotic mycelium, which represents the vegetative stage responsible for substrate colonization. Environmental factors such as temperature, humidity, light intensity, carbon dioxide concentration, and substrate composition trigger fruiting body initiation. Mature mushrooms subsequently produce basidiospores or ascospores, completing the reproductive cycle. Based on nutritional ecology, medicinal mushrooms can be classified into three major groups:  Saprophytic mushrooms-Grow on dead organic matter and agricultural residues (e.g., Ganoderma lucidum, Lentinula edodes, Pleurotus spp., Hericium erinaceus).  Parasitic mushrooms-Obtain nutrients from living hosts (e.g., Cordyceps spp.).  Mycorrhizal mushrooms-Form symbiotic associations with plant roots (certain medicinal species with limited commercial cultivation).

Economic Importance of Medicinal Mushrooms

Medicinal mushrooms have emerged as one of the most profitable sectors of modern agriculture due to their high market value, rising consumer demand, and diverse applications across the pharmaceutical, nutraceutical, cosmetic, and functional food industries. Unlike conventional edible mushrooms, medicinal species command premium prices due to the presence of bioactive compounds such as βglucans, polysaccharides, triterpenoids, lectins, terpenes, sterols, and phenolic compounds. These compounds are extensively utilized in the manufacture of dietary supplements, herbal medicines, immune boosters, protein powders, beverages, cosmetics, and pharmaceutical formulations (Wasser, 2011;El Enshasy et al., 2022) [6,7] . Medicinal mushroom cultivation provides an attractive livelihood option for small and marginal farmers because it requires relatively little land, can be practiced year-round under controlled conditions, and efficiently utilizes agricultural residues such as wheat straw, rice straw, sawdust, sugarcane bagasse, cotton waste, and maize stalks. This not only reduces production costs but also converts low-value lignocellulosic biomass into high-value products, contributing to waste recycling and the circular bioeconomy (Chang and Wasser, 2017;El Enshasy et al., 2022;Aditya et al., 2023a) [8,7,4] . Commercial cultivation generates employment throughout the value chain, including spawn production, substrate preparation, cultivation, harvesting, processing, packaging, transportation, marketing, and export. The industry has created entrepreneurial opportunities for rural youth, women self-help groups, farmer-producer organizations, and agribusiness startups. Furthermore, value-added products such as mushroom extracts, capsules, tablets, teas, coffee blends, nutraceuticals, and cosmetics substantially increase profit margins compared with fresh mushrooms (Royse et al., 2017; Divya et al., 2024) [9] . International demand for medicinal mushrooms continues to grow due to rising awareness of preventive healthcare and natural therapeutics. Species such as Ganoderma lucidum, Cordyceps militaris, Hericium erinaceus, and Lentinula edodes are now traded globally as dried fruiting bodies, extracts, powders, and standardized nutraceutical ingredients. Consequently, medicinal mushroom cultivation represents a promising export-oriented enterprise with considerable foreign exchange earning potential (El Enshasy et al., 2022) [7] .

Cultivation Technologies

Successful cultivation of medicinal mushrooms depends on selecting suitable species, preparing high-quality spawn, using appropriate substrates, maintaining optimum environmental conditions, and adopting effective crop management practices. Over the past four decades, cultivation technologies have evolved from traditional log cultivation to highly sophisticated controlled-environment production systems that maximize yield, quality, and biological efficiency (El Enshasy et al., 2022) [7] .

Log Cultivation

Log cultivation is the oldest technique used for producing medicinal mushrooms, particularly Lentinula edodes and Ganoderma lucidum. Hardwood logs such as oak, beech, maple, and poplar are inoculated with spawn and incubated under shaded, humid conditions. Although production requires several months before harvesting begins, this method produces premiumquality fruiting bodies with excellent medicinal properties. The major disadvantages include long incubation periods, seasonal dependence, and comparatively lower productivity (Chang and Wasser, 2017) [8] .

Bag Cultivation

Bag cultivation is the most widely adopted commercial method because of its simplicity, low investment, and efficient utilization of agricultural residues. Sterilized substrates such as sawdust, wheat straw, rice straw, maize cobs, sugarcane bagasse, or cotton waste are filled into polypropylene bags and inoculated with mushroom spawn. After completing mycelial colonization, environmental conditions are modified to induce fruiting. This system provides higher biological efficiency, shorter production cycles, reduced contamination, and improved product uniformity.

Bottle Cultivation

Bottle cultivation is extensively practiced in Japan, South Korea, and China for species such as Hericium erinaceus, Flammulina velutipes, and Ganoderma lucidum. Sterilized bottles containing formulated sawdust-based substrate are inoculated mechanically, allowing automation of filling, inoculation, incubation, harvesting, and cleaning. This technology is suitable for industrial-scale production requiring consistent quality and high productivity (Royse et al., 2017) [9] .

Controlled Environment Cultivation

Modern medicinal mushroom production increasingly employs environmentally controlled growing chambers equipped with automated systems regulating temperature, humidity, carbon dioxide concentration, ventilation, and illumination. Controlled cultivation minimizes seasonal variability, improves biological efficiency, reduces contamination, and enables year-round production of premium-quality mushrooms. Integration of Internet of Things (IoT), sensorbased monitoring, automation, and artificial intelligence has further improved crop management and production efficiency.

Environmental Requirements

Environmental conditions strongly influence mycelial growth, fruiting body initiation, biological efficiency, and the accumulation of medicinal metabolites. Different mushroom species require specific environmental conditions; however, most medicinal mushrooms exhibit similar general requirements.

Temperature

Temperature is one of the most critical factors affecting mushroom growth. Mycelial colonization generally occurs between 22-28 °C, while fruiting requires comparatively lower temperatures depending on the species. [11,10] .

Relative Humidity

High relative humidity (85-95%) is essential during fruiting to maintain proper moisture content and prevent drying of developing fruiting bodies. Low humidity causes cracking, deformation, and reduced yield, whereas excessive moisture promotes bacterial and fungal contamination.

Carbon Dioxide

Mycelial growth generally benefits from elevated carbon dioxide concentrations, whereas fruiting body formation requires adequate ventilation to reduce CO₂ accumulation. High CO₂ levels during fruiting result in elongated stipes, malformed fruiting bodies, and poor quality. Therefore, fresh air exchange is an essential management practice in commercial production.

Light

Unlike green plants, mushrooms do not require light for photosynthesis. However, lowintensity diffused light (approximately 300-800 lux for several hours daily) acts as an environmental signal that stimulates primordia formation, pigmentation, and normal fruiting body development. Complete darkness often suppresses fruiting in many medicinal species.

pH

Most medicinal mushrooms grow best on substrates with a slightly acidic pH ranging from 5.5 to 6.5. Maintaining the proper pH promotes efficient nutrient availability, supports vigorous mycelial colonization, and suppresses competing microorganisms.

Spawn Production

Spawn serves as the planting material (seed) of mushroom cultivation and is considered the foundation of successful commercial production. High-quality spawn ensures rapid substrate colonization, minimizes contamination, shortens cropping duration, and significantly improves yield and biological efficiency (Chang and Miles, 2004; Aditya et al., b; Raza et al., 2026) [12] . Spawn production begins with the isolation of pure fungal cultures from healthy fruiting bodies or tissue cultures under aseptic laboratory conditions. The culture is maintained on Potato Dextrose Agar (PDA) or Malt Extract Agar (MEA), where vigorous mycelial growth is established before multiplication. The most commonly used commercial spawn is cereal grain spawn prepared from wheat, sorghum, pearl millet, rye, or maize grains. The grains are cleaned, soaked, boiled, drained, and supplemented with calcium carbonate and gypsum to prevent clumping and maintain suitable pH. After filling into autoclavable bottles or polypropylene bags, the grains are sterilized at 121 °C under 15 psi pressure for 1-2 hours. Sterile grain is then inoculated with actively growing mycelium in a laminar airflow cabinet and incubated until complete colonization. Quality spawn should exhibit vigorous, uniform white mycelial growth, absence of contamination, high viability, genetic purity, and rapid colonization ability. Poorquality spawn often leads to delayed growth, contamination, reduced biological efficiency, and substantial economic losses. Recent studies emphasize that spawn type, spawn rate, and spawn quality are among the most influential determinants of commercial mushroom productivity.

Substrate Selection and Preparation

The substrate serves as both the physical support and nutrient source for medicinal mushroom cultivation. Selection of an appropriate substrate is crucial because it directly influences mycelial colonization, biological efficiency, fruiting body quality, medicinal compound accumulation, and production economics.

Most medicinal mushrooms are lignocellulosedegrading fungi capable of converting agricultural and forestry residues into valuable biomass through extracellular enzymatic activity (Chang and Wasser, 2017) [8] .

Common substrates include:

Supplementation with wheat bran, rice bran, soybean meal, gypsum, and calcium carbonate enhances nitrogen availability and improves mushroom yield. The substrate is adjusted to approximately 60-65% moisture, filled into cultivation bags or bottles, and sterilized or pasteurized before inoculation. Sterilization at 121 °C effectively eliminates competing microorganisms and ensures successful spawn establishment, particularly for medicinal mushrooms requiring prolonged incubation periods. Proper substrate preparation includes chopping (where required), soaking, moisture adjustment, pH correction, supplementation, bag filling, sterilization, cooling, inoculation under aseptic conditions, and incubation. High-quality substrates should possess adequate porosity, balanced carbonto-nitrogen ratio, good water-holding capacity, and freedom from contaminants. Optimized substrate formulations not only improve biological efficiency but also enhance the concentration of therapeutically important bioactive compounds, thereby increasing the commercial value of medicinal mushrooms.

Substrate Selection and Preparation

The substrate serves as the primary nutrient source and physical support for the growth of medicinal mushrooms. Selection of an appropriate substrate is one of the most critical determinants of mycelial colonization, fruiting body development, biological efficiency, and the production of bioactive compounds. Most medicinal mushrooms are lignocellulolytic fungi capable of degrading cellulose, hemicellulose, and lignin through extracellular enzymes such as cellulases, xylanases, laccases, lignin peroxidases, and manganese peroxidases, enabling the utilization of a wide range of agricultural and forestry residues (Chang and Miles, 2004;Sánchez, 2010;El Enshasy et al., 2022) [12,13,7] . The use of agricultural wastes as cultivation substrates significantly reduces production costs while promoting environmental sustainability through biomass recycling. Common substrates include wheat straw, rice straw, sawdust, sugarcane bagasse, maize stalks, cotton waste, coffee husks, tea waste, coconut coir, bamboo leaves, hardwood chips, sunflower stalks, and corn cobs. Hardwood sawdust remains the preferred substrate for species such as Ganoderma lucidum, Lentinula edodes, and Hericium erinaceus, whereas straw-based substrates are commonly used for Pleurotus spp. and several medicinal mushrooms under commercial cultivation (Royse et al., 2017;Grimm and Wösten, 2018) [9,14] . To improve productivity, substrates are supplemented with nitrogen-rich materials such as wheat bran, rice bran, soybean meal, maize flour, gypsum (CaSO₄), and calcium carbonate (CaCO3). These supplements improve the carbon-to-nitrogen ratio, enhance mycelial growth, and increase fruiting body yield. However, excessive supplementation may encourage contamination by competitor microorganisms; therefore, balanced substrate formulation is essential (Sánchez, 2010) [13] . Substrate preparation involves several sequential steps. Initially, raw materials are cleaned and chopped into small pieces to improve handling and colonization. The substrate is then soaked in water to achieve an optimum moisture content of approximately 60-65%, followed by draining excess water. The pH is adjusted to 5.5-6.5 using calcium carbonate or gypsum where necessary. Supplementary nutrients are mixed thoroughly before filling the substrate into polypropylene bags or cultivation bottles (Chang and Miles, 2004) [12] . Sterilization or pasteurization is essential for eliminating competing microorganisms. For medicinal mushrooms, sterilization is generally preferred because of the long incubation period. Substrate-filled bags are sterilized in an autoclave at 121 °C and 15 psi for 1-2 hours depending on bag size. After cooling to room temperature, inoculation is performed under aseptic conditions using high-quality grain spawn in a laminar airflow cabinet. Proper substrate preparation ensures rapid mycelial colonization, minimizes contamination, and enhances both yield and medicinal quality (El Enshasy et al., 2022) [7] .

Crop Management

Efficient crop management is essential for maximizing biological efficiency, improving fruiting body quality, and minimizing crop losses due to contamination and environmental stress. Successful medicinal mushroom cultivation requires continuous monitoring of temperature, humidity, ventilation, light intensity, carbon dioxide concentration, sanitation, and crop health throughout the production cycle (Royse et al., 2017) [9] . Following inoculation, cultivation bags are transferred to incubation rooms maintained under optimum environmental conditions suitable for mycelial growth. During this phase, temperatures ranging between 22-28 °C, relative humidity of 70-80%, and minimal light are maintained depending on the species. Complete substrate colonization generally requires 20-60 days, although the duration varies with mushroom species, substrate composition, and spawn quality (Chang and Miles, 2004) [12] . After complete mycelial colonization, environmental conditions are modified to induce fruiting body formation. Relative humidity is increased to 85-95%, while fresh air exchange is enhanced to reduce carbon dioxide concentration. Diffused light (approximately 300-800 lux) is provided for several hours daily to stimulate primordia initiation. Regular monitoring of environmental parameters ensures uniform fruiting and minimizes physiological disorders such as malformed fruiting bodies, elongated stipes, or reduced cap development (Grimm and Wösten, 2018) [14] .

Sanitation is a critical component of crop management. Cultivation rooms, equipment, and workers should maintain strict hygiene practices to prevent contamination from molds such as Trichoderma, Penicillium and Aspergillus, as well as bacterial pathogens. Infected bags should be removed immediately to prevent disease spread. Integrated pest management strategies involving physical sanitation, biological control, and proper environmental regulation are preferred over chemical pesticides because medicinal mushrooms are consumed as healthpromoting products (Sánchez, 2010) [13] . Modern commercial mushroom farms increasingly employ automated environmental control systems integrated with sensors, programmable controllers, IoT platforms, and artificial intelligence. These technologies enable real-time monitoring of temperature, humidity, carbon dioxide concentration, and ventilation, thereby improving crop uniformity, reducing labor costs, and increasing production efficiency (El Enshasy et al., 2022) [7] .

Harvesting and Post-harvest Management

Harvesting at the appropriate stage is essential to maximize yield, medicinal quality, and market value. The optimum harvesting stage varies among species. Ganoderma lucidum is generally harvested after complete maturation and spore formation, whereas Lentinula edodes and Hericium erinaceus are harvested before excessive cap expansion or spine elongation to preserve texture and bioactive compound concentration (Chang and Wasser, 2017) [8] . Harvesting is performed manually using sterile knives or by gently twisting the fruiting body from the substrate without damaging the remaining mycelium. Careful handling reduces mechanical injuries and minimizes microbial contamination. After harvesting, residual substrate adhering to the mushroom base is removed before grading and packaging. Fresh medicinal mushrooms contain 85-95% moisture, making them highly perishable. Consequently, immediate post-harvest management is necessary to preserve quality. Fresh mushrooms intended for local markets are stored at 2-4 °C with high relative humidity, extending shelf life to approximately one week depending on the species (Royse et al., 2017) [9] . For long-term preservation, mushrooms are dehydrated using hot-air drying, vacuum drying, freeze-drying, solar drying, or microwave-assisted drying. Freeze-drying is considered the best technique because it preserves polysaccharides, antioxidants, vitamins, aroma, and medicinal compounds more effectively than conventional drying methods. Properly dried mushrooms containing less than 10% moisture can be stored for several months without significant deterioration (El Enshasy et al., 2022;Bhatia et al., 2025b) [7,15,16] . Packaging materials such as vacuum-sealed laminated pouches, polyethylene bags, moisture-proof containers, and modified atmosphere packaging protect dried products from moisture absorption, oxidation, and microbial contamination during storage and transportation.

Processing and Value Addition

Value addition substantially enhances the profitability of medicinal mushroom enterprises by converting fresh mushrooms into diversified commercial products with extended shelf life and higher market value. The pharmaceutical and nutraceutical industries increasingly utilize mushroom-derived bioactive compounds for manufacturing functional foods, dietary supplements, cosmetics, and herbal medicines (Wasser, 2011;Aditya et al., 2024b) [6,17,18] . The simplest value-added products include dried whole mushrooms, mushroom powder, tea formulations, instant soups, seasoning mixes, coffee blends, noodles, biscuits, chocolates, beverages, capsules, and tablets. Drying and pulverization facilitate convenient storage, transportation, and incorporation into various food formulations while retaining most medicinal constituents (Patel and Goyal, 2012; Bhatia et al., 2024) [19,20] [7] . Mushroom-derived ingredients are also widely utilized in cosmetic products such as anti-aging creams, moisturizers, facial masks, shampoos, and skin serums because of their antioxidant, antiinflammatory, and skin-regenerating properties. Furthermore, spent mushroom substrate has commercial applications as organic manure, vermicompost, livestock feed, enzyme production substrate, biofertilizer, and bioenergy feedstock, thereby increasing resource-use efficiency and supporting circular agriculture (Sánchez, 2010) [13] .

Bioactive Compounds and Therapeutic Properties

The medicinal value of mushrooms is attributed to their diverse array of biologically active compounds synthesized during mycelial growth and fruiting body development. These compounds exhibit multiple pharmacological activities that have been scientifically validated through in vitro, animal, and clinical investigations (Wasser, 2011) [6] . Polysaccharides, particularly β-glucans, represent the most extensively studied medicinal constituents. β-glucans stimulate macrophages, dendritic cells, natural killer cells, and T lymphocytes, thereby enhancing innate and adaptive immune responses. Numerous studies have demonstrated their immunomodulatory and anticancer properties (Boh et al., 2007; Aditya et al., a; Aditya et al., b) [21] . Triterpenoids, predominantly found in Ganoderma lucidum, possess anti-inflammatory, hepatoprotective, antihypertensive, antiviral, antioxidant, and cholesterol-lowering activities. These compounds also exhibit promising anticancer effects through apoptosis induction and inhibition of tumor angiogenesis (Paterson, 2006; Bhatia et al., a) [22] . Other important bioactive constituents include phenolic compounds, flavonoids, sterols (ergosterol), lectins, peptides, terpenes, glycoproteins, nucleosides (cordycepin), hericenones, erinacines, and eritadenine. These compounds exhibit antioxidant, antimicrobial, antiviral, neuroprotective, antidiabetic, cardioprotective, hepatoprotective, nephroprotective, and cholesterol-lowering effects (Patel and Goyal, 2012) [19] . Species-specific bioactive compounds include lentinan from Lentinula edodes, cordycepin from Cordyceps militaris, hericenones and erinacines from Hericium erinaceus, PSK and PSP from Trametes versicolor, and D-fraction polysaccharides from Grifola frondosa. These compounds are widely investigated as adjunct therapies for cancer, neurodegenerative diseases, diabetes, obesity, and immune dysfunction (El Enshasy et al., 2022) [7] .

Cost of Cultivation and Economic Analysis

Economic viability is one of the primary factors determining the commercial success of medicinal mushroom cultivation. Compared with many horticultural enterprises, medicinal mushrooms require relatively limited land resources while generating high-value products with substantial profit margins. Production costs vary according to mushroom species, cultivation technology, substrate availability, scale of operation, labor charges, and level of mechanization (Royse et al., 2017) [9] . The major cost components include infrastructure development, spawn procurement or production, substrate materials, supplements, sterilization, labor, environmental control systems, packaging, transportation, marketing, and electricity. In commercial production units, infrastructure and environmental control generally account for the highest initial investment, whereas substrate and spawn constitute the major recurring production costs (Chang and Miles, 2004; Aditya and Bhatia, 2020) [12,23] . The use of locally available agricultural residues substantially reduces production costs while improving profitability. Farmers utilizing wheat straw, rice straw, sugarcane bagasse, sawdust, or other locally available lignocellulosic materials achieve lower input costs than those relying on commercially formulated substrates. Additionally, on-farm spawn production can further decrease operational expenses, provided adequate laboratory facilities and technical expertise are available (Sánchez, 2010) [13] . Value addition significantly enhances economic returns. Fresh mushrooms generally command lower market prices than processed products such as dried mushrooms, standardized extracts, capsules, nutraceutical formulations, herbal teas, and medicinal powders. Processing also extends shelf life, reduces post-harvest losses, and facilitates export, thereby increasing overall profitability (Patel and Goyal, 2012) [19] . Economic analyses from commercial farms indicate that wellmanaged medicinal mushroom enterprises can achieve favourable benefit-cost (B:C) ratios, particularly when integrated with value addition and direct marketing strategies. Premium medicinal species such as Ganoderma lucidum, Cordyceps militaris, and Hericium erinaceus generally provide substantially higher net returns than common edible mushrooms because of their higher market prices and expanding demand in pharmaceutical and nutraceutical industries (El Enshasy et al., 2022) [7] .

Marketing and Export Opportunities

Medicinal mushrooms have emerged as high-value agricultural commodities owing to their expanding applications in nutraceuticals, pharmaceuticals, functional foods, cosmetics, and dietary supplements. The growing consumer preference for natural and plant-based healthcare products has substantially increased the global demand for medicinal mushrooms such as Ganoderma lucidum, Lentinula edodes, Cordyceps militaris, Hericium erinaceus, Grifola frondosa, and Trametes versicolor(Royseet al., 2017;El Enshasy et al., 2022) [9,7] . The global medicinal mushroom market has witnessed remarkable growth due to increasing awareness of preventive healthcare, aging populations, and the rising prevalence of chronic diseases. Consumers are increasingly seeking products with scientifically validated health benefits, creating substantial market opportunities for mushroom-based nutraceuticals and functional foods (Wasser, 2011;Patel and Goyal, 2012) [6,19] . Dried mushrooms, powdered formulations, aqueous and alcoholic extracts, capsules, tablets, herbal teas, coffee blends, functional beverages, cosmetics, and immune-enhancing supplements constitute the major commercial products traded in domestic and international markets (Kalač, 2016) [24] . Commercial marketing of medicinal mushrooms follows multiple channels, including direct farm sales, wholesalers, supermarkets, pharmacies, health food stores, online marketplaces, nutraceutical companies, pharmaceutical manufacturers, and export agencies. Digital marketing and ecommerce platforms have significantly expanded market accessibility by enabling producers to reach consumers directly while reducing dependence on intermediaries. Branding, quality certification, attractive packaging, traceability, and compliance with food safety standards play crucial roles in improving consumer confidence and product competitiveness (Royse et al., 2017) [9] . International trade in medicinal mushrooms has expanded considerably during the last two decades. China remains the world's largest producer and exporter, followed by Japan, South Korea, Taiwan, the United States, and several European countries. These nations have established advanced cultivation technologies, standardized processing industries, and well-developed export infrastructure that ensure consistent product quality (Chang and Wasser, 2017) [8] . India possesses significant export potential due to favourable agro-climatic conditions, abundant agricultural residues, comparatively lower production costs, and increasing investments in mushroom cultivation. The export of dried mushrooms, mushroom powders, extracts, and nutraceutical products is gradually increasing, particularly to markets in North America, Europe, Southeast Asia, Australia, and the Middle East. However, successful international marketing requires adherence to Good Agricultural Practices (GAP), Good Manufacturing Practices (GMP), Hazard Analysis and Critical Control Point (HACCP), ISO quality standards, organic certification, and international phytosanitary regulations (FAO, 2021). The commercialization of value-added products significantly enhances profitability compared to the sale of fresh mushrooms alone. Processing medicinal mushrooms into standardized extracts, pharmaceutical ingredients, nutraceutical capsules, herbal beverages, protein supplements, and cosmetic products provides substantially higher returns while reducing postharvest losses and extending shelf life (El Enshasy et al., 2022) [7] . Future growth of the medicinal mushroom industry will depend on market diversification, consumer education, quality assurance, and international certification systems.

Government Schemes and Entrepreneurship

Medicinal mushroom cultivation has become an important component of agricultural diversification, rural development, and agri-entrepreneurship. Governments across the world increasingly recognize mushroom farming as a sustainable enterprise capable of generating employment, enhancing farmers' income, utilizing agricultural wastes, and promoting environmentally friendly agricultural production systems (FAO, 2021) [25] . Government financial assistance includes subsidies for mushroom production units, spawn laboratories, environmental control systems, processing facilities, cold storage, and postharvest infrastructure. Credit facilities are available through NABARD-supported schemes, commercial banks, cooperative institutions, and various startup promotion programmes. Young entrepreneurs, women self-help groups, farmer-producer organizations (FPOs), and rural youth are increasingly encouraged to establish commercial mushroom enterprises through entrepreneurship development initiatives (NABARD, 2022). The Government of India also promotes organic farming, sustainable agriculture, and waste recycling through various national programmes, creating favorable conditions for medicinal mushroom cultivation. Since mushrooms efficiently utilize agricultural residues and generate valuable organic manure through spent mushroom substrate, they contribute directly to circular agriculture and climatesmart farming systems (Sánchez, 2010) [13] . Entrepreneurship opportunities extend beyond fresh mushroom production. Commercial ventures include spawn production laboratories, mushroom processing industries, nutraceutical manufacturing, medicinal extract production, functional food development, organic fertilizer production from spent substrate, mushroom training centres, consultancy services, and export-oriented businesses. These diversified enterprises create multiple income streams while reducing production risks (Chang and Miles, 2004) [12] . Future government policies should emphasize improved access to credit, quality certification, export facilitation, incubation centres, startup support, and public-private partnerships to accelerate the commercialization of medicinal mushroom technologies and strengthen the rural bioeconomy.

Constraints and Challenges

Despite significant commercial potential, medicinal mushroom cultivation faces numerous technical, economic, environmental, and institutional challenges that limit its widespread adoption and industrial growth. Addressing these constraints is essential for achieving sustainable and profitable production systems (Royse et al., 2017) [9] . One of the most critical challenges is contamination by competing fungi, bacteria, and insects during spawn production and substrate colonization. Species such as Trichoderma, Aspergillus, Penicillium, and bacterial contaminants frequently reduce biological efficiency and cause substantial economic losses. Maintenance of strict aseptic conditions and quality spawn production remains essential for successful cultivation (Chang and Miles, 2004) [12] . Availability of genetically superior, disease-free, and high-quality spawn is another major limitation, particularly in developing countries. Inadequate laboratory infrastructure, limited technical expertise, and insufficient quality control frequently result in poor spawn performance and inconsistent crop yields (ICAR-DMR, 2023) [25] . Environmental control constitutes another significant challenge. Many medicinal mushroom species require precise regulation of temperature, humidity, carbon dioxide concentration, and ventilation. Maintaining these conditions throughout the year often necessitates expensive environmental control systems and continuous electricity supply, increasing production costs (Grimm and Wösten, 2018) [14] . Market-related constraints include fluctuating prices, inadequate consumer awareness, absence of standardized quality grading systems, limited processing infrastructure, and insufficient market linkages. Small-scale farmers frequently depend on local markets where demand for medicinal mushrooms remains relatively limited compared to conventional edible mushrooms (Patel and Goyal, 2012) [19] . Post-harvest deterioration presents another important challenge because fresh mushrooms possess high moisture content and limited shelf life. Lack of cold chain facilities, drying units, and processing industries contributes to considerable post-harvest losses and reduced profitability (Kalač, 2016) [24] . Regulatory issues also affect commercialization. Variations in international regulations governing nutraceuticals, herbal medicines, food supplements, and pharmaceutical products complicate export procedures. Scientific validation, standardization of bioactive compounds, traceability, and quality certification remain important prerequisites for accessing premium international markets (FAO, 2021). Climate change poses emerging challenges by influencing substrate availability, energy requirements, and environmental control costs. Sustainable production systems integrating renewable energy, improved waste management, and climate-resilient technologies will become increasingly important for future medicinal mushroom industries.

Recent Advances (AI, IoT, Automation, and Precision Mushroom Farming)

Recent technological innovations have transformed medicinal mushroom cultivation from traditional manual practices into highly sophisticated precision production systems. Integration of digital technologies, automation, artificial intelligence (AI), Internet of Things (IoT), robotics, biotechnology, and data analytics has significantly improved production efficiency, crop monitoring, quality control, and economic profitability (El Enshasy et al., 2022) [7] . IoTbased environmental monitoring systems employ wireless sensors to continuously measure temperature, humidity, carbon dioxide concentration, substrate moisture, light intensity, and ventilation. Real-time monitoring enables automatic adjustment of environmental conditions, minimizing human error while improving biological efficiency and reducing production costs (Grimm and Wösten, 2018) [14] . Artificial intelligence has emerged as an important tool for intelligent crop management. Machine learning algorithms analyze environmental data to optimize irrigation schedules, ventilation rates, humidity management, and harvesting time. AI-assisted image analysis also facilitates early detection of contamination, diseases, and physiological disorders before visible symptoms become severe, thereby reducing production losses (Li et al., 2023) [26] . Automation technologies have significantly reduced labor requirements in commercial mushroom farms. Automated substrate mixing, bag filling, sterilization, inoculation, bottle cultivation, harvesting, grading, packaging, and environmental control systems improve productivity while maintaining consistent product quality. Robotic harvesting systems are currently under development for industrial-scale mushroom production (Royse et al., 2017) [9] . Precision mushroom farming integrates sensor networks, cloud computing, mobile applications, geographic information systems (GIS), artificial intelligence, and decision support systems to optimize resource utilization. These technologies enable growers to maximize yield while minimizing energy consumption, water use, and production costs. Smart cultivation facilities equipped with remote monitoring and automated climate control have become increasingly common in developed countries. Biotechnological advances including molecular breeding, genomic sequencing, CRISPR-based genome editing, markerassisted selection, metabolomics, transcriptomics, and proteomics are providing new opportunities for developing high-yielding strains with improved medicinal properties, enhanced disease resistance, and superior environmental adaptability (Money, 2016) [27] .

Future Research Priorities

Although substantial progress has been achieved in medicinal mushroom research, several scientific and technological challenges remain unresolved. Future investigations should emphasize multidisciplinary approaches integrating mycology, biotechnology, molecular biology, agricultural engineering, food science, pharmacology, and economics. Development of genetically improved mushroom strains possessing higher biological efficiency, enhanced bioactive compound production, disease resistance, and environmental tolerance should remain a major research priority. Modern molecular breeding techniques including genome sequencing, gene editing, marker-assisted selection, and genomic prediction offer promising opportunities for accelerating strain improvement (Money, 2016) [27] . Optimization of substrate formulations using locally available agricultural residues should receive greater research attention. Studies investigating carbon-to-nitrogen ratio, supplementation strategies, microbial interactions, and enzyme activities may substantially improve production efficiency while reducing cultivation costs (Sánchez, 2010) [13] . Further investigations are required to standardize extraction technologies for medicinal compounds and establish internationally accepted quality standards for nutraceutical products. Comprehensive clinical trials evaluating safety, efficacy, pharmacokinetics, dosage, and therapeutic mechanisms are necessary to strengthen scientific evidence supporting medicinal mushroom applications (Patel and Goyal, 2012) [19] . Digital agriculture will play an increasingly important role in future mushroom cultivation. Research should focus on AIassisted decision support systems, predictive modeling, autonomous cultivation systems, smart sensors, blockchainbased traceability, digital twins, and precision environmental management. These innovations will contribute to sustainable, resource-efficient, and climate-resilient mushroom production systems. Greater emphasis should also be placed on life-cycle assessment, carbon footprint analysis, renewable energy integration, waste valorization, and circular bioeconomy approaches to improve environmental sustainability. International collaboration among research institutions, industries, governments, and policymakers will be essential for accelerating commercialization and global adoption of advanced medicinal mushroom technologies.

Conclusion

Medicinal mushrooms represent one of the most promising sectors of modern sustainable agriculture because of their exceptional nutritional, medicinal, environmental, and economic importance.

Acknowledgement

AcknowledgementsThe authors express their sincere gratitude to the Department of Agriculture, Shivalik College of Engineering, Dehradun, Uttarakhand, India, for providing academic support and research facilities during the preparation of this review. The authors also acknowledge researchers and institutions worldwide whose published scientific contributions have greatly enriched the understanding of medicinal mushroom cultivation, bioactive compounds, and commercial applications.

References

1. Aditya, Bhatia JN, Yadav AN. A comprehensive review on multifunctional bioactive properties of elm oyster mushroom Hypsizygus ulmarius (Bull.) Redhead (Agaricomycetes): Current research, challenges and future trends. Heliyon. 2025;11(2):e41418.
2. Aditya, Neeraj, Bhatia JN, Reddy KR, Sihag S. Biotechnology advances and future prospects in the recycling of agricultural solid waste: A path to sustainable waste management. In: Waste to Wealth: Emerging Technologies for Sustainable Development (ISBN: 978-10034-4910-2). CRC Press, Boca Raton. 2025;144-171.
3. Aditya, Jarial RS. Utilization of agro-industrial wastes and organic supplements for cultivation of blue oyster mushroom. Bangladesh Journal of Botany. 2023;52(1):179-185.
4. Aditya, Jarial RS, Bhatia JN. Performance of various agroforestry wastes for the cultivation of elm oyster mushroom Hypsizygus ulmarius (Agaricomycetes) in India and its biochemical constituents. International Journal of Medicinal Mushrooms. 2023;25(8):55-62.
5. Wasser SP. Current findings, future trends, and unsolved problems in studies of medicinal mushrooms. Applied Microbiology and Biotechnology. 2011;89(5):1323-1332.
6. El Enshasy HA, Hatti-Kaul R, Daba A. Current advances in medicinal mushroom cultivation and therapeutic applications. Molecules. 2022;27(21):7321.
7. Royse DJ, Baars J, Tan Q. Current overview of mushroom production in the world. In D. C. Zied & A. PardoGiménez (Eds.), Edible and Medicinal Mushrooms: Technology and Applications. Wiley-Blackwell. 2017:513.
8. 10. Aditya, Jarial RS, Jarial K. Laboratory screening of different nutrient media for mycelial growth and cultural characteristics of blue oyster mushroom [Hypsizygus ulmarius (Bull.: Fr.) Redhead]. Indian Journal of Ecology. 2022;49(3):826-830.
9. Aditya, Jarial RS, Jarial K. Performance evaluation of substrates for cultivation of blue oyster mushroom. Indian Journal of Horticulture. 2022;79(3):323-329.
10. Chang ST, Miles PG. Mushrooms: Cultivation, Nutritional Value, Medicinal Effect, and Environmental Impact (2nd ed.). CRC Press; 2004.
11. Sánchez C. Cultivation of Pleurotus spp. and other edible mushrooms. Applied Microbiology and Biotechnology. 2010;85(5):1321-1337.
12. Grimm D, Wösten HAB. Mushroom cultivation in the circular economy. Applied Microbiology and Biotechnology. 2018;102(18):7795-7803.
13. Bhatia A, Neeraj, Bhatia JN. Amplification and quantification of lovastatin from elm oyster mushroom Hypsizygus ulmarius (Bull.) Redhead (Agaricomycetes) through HPLC analysis and determination of its mycochemical constituents. ACS Food Science & Technology. 2025;5(1):368-377.
14. 16. Bhatia A, Neeraj, Bhatia JN, Jarial RS, Jarial K. Cultivation technology optimization and identification of secondary metabolites from elm oyster mushroom Hypsizygus ulmarius (Bull.) Redhead (Agaricomycetes) through GC-MS metabolomic profiling from India. Mycologia. 2025;117(2):1-27.
15. Aditya, Kumar D, Kashyap S, Gupta S. Mushrooms as functional foods: Trends and innovations. In: Mushroom Magic (ISBN: 978-1-0035-7025-7). CRC Press, London. 2024;307-322.
16. Aditya, Neeraj, Bhatia JN. Escalating vitamin D2 content in fresh sporocarps of elm oyster mushroom Hypsizygus ulmarius (Bull.) Redhead (Agaricomycetes) using ultraviolet irradiation and assessment of its stability, antioxidant capacity, color, and textural properties. ACS Food Science & Technology. 2024;4(11):2739-2751.
17. Patel S, Goyal A. Recent developments in mushrooms as anti-cancer therapeutics. 3 Biotech. 2012;2(1):1-15.
18. Bhatia A, Neeraj, Jarial RS, Jarial K, Bhatia JN. Comprehensive review on oyster mushroom species (Agaricomycetes): Morphology, nutrition, cultivation and future aspects. Heliyon. 2024;10(5):e26539.
19. Boh B, Berovic M, Zhang J, Zhi-Bin L. Ganoderma lucidum and its pharmaceutically active compounds. Biotechnology Annual Review. 2007;13:265-301.
20. Paterson RRM. Ganoderma-A therapeutic fungal biofactory. Phytochemistry. 2006;67(18):1985-2001.
21. Aditya, Bhatia JN. Economic empowerment of rural women through mushroom farming. International Journal of Current Microbiology and Applied Sciences. 2020;9(6):1081-1089.
22. Kalač P. Edible Mushrooms: Chemical Composition and Nutritional Value. Academic Press; 2016.
23. ICAR-Directorate of Mushroom Research. Annual Report 2022-23. Solan, Himachal Pradesh, India; 2023.
24. Li H, Wang X, Zhang Y, Liu J. Artificial intelligence applications in mushroom cultivation and disease detection. Computers and Electronics in Agriculture. 2023;210:107923.
25. Money NP. Are Mushrooms Medicines? Fungal Biology Reviews. 2016;30(4):157-163.
26. Adebayo EA, Oloke JK. Oyster mushroom (Pleurotus species): A natural functional food. Journal of Microbiology, Biotechnology and Food Sciences. 2017;7(3):254-264.
27. Al Qutaibi M, Kagne SR. Exploring the phytochemical compositions, antioxidant activity, and nutritional potentials of edible and medicinal mushrooms. International Journal of Microbiology. 2024;2024:6660423.
28. Alam N, Amin R, Khan A, Ara I, Shim MJ, Lee MW, et al. Nutritional analysis of cultivated mushrooms in Bangladesh. Mycobiology. 2008;36(4):228-232.
29. Alananbeh KM, Bouqellah NA, Al Kaff NS. Cultivation of oyster mushroom on date-palm leaves mixed with other agricultural wastes. Saudi Journal of Biological Sciences. 2014;21(6):616-620.
30. Ambhore JP, Adhao VS, Rafique SS, Telgote AA, Dhoran RS, Shende BA. A concise review: Edible mushrooms and their medicinal significance. Exploration of Foods and Foodomics. 2024;2:1001033.
31. Annepu SK. Advances in commercial mushroom cultivation. Directorate of Mushroom Research, ICAR. 2021.
32. Badalyan SM. Potential of medicinal mushrooms in modern medicine. International Journal of Medicinal Mushrooms. 2014;16(1):1-15.
33. Badalyan SM. Medicinal mushrooms in the twenty-first century: Current trends and future perspectives. International Journal of Medicinal Mushrooms. 2020;22(8):715-729.
34. Balan V. Current status of medicinal mushroom biotechnology. Biotechnology Letters. 2021;43(10):19151930.
35. Barros L, Ferreira ICFR, Heleno SA. Nutritional chemistry and bioactive compounds of edible mushrooms. Food Chemistry. 2021;337:127845.
36. Barua RC, Coniglio RO, Molina MA, Díaz GV, Fonseca MI. Fungi as biotechnological allies: Exploring contributions of edible and medicinal mushrooms. Journal of Food Science. 2024;89(11):6888-6915.
37. Beelman RB, Royse DJ, Chikthimmah N, Wanasinghe DN. Functional properties of mushrooms in human nutrition. Current Opinion in Food Science. 2020;32:1-8.
38. Bernas E, Jaworska G, Lisiewska Z. Edible mushrooms as a source of valuable nutrients. Acta Scientiarum Polonorum Technologia Alimentaria. 2006;5(1):5-20.
39. Breene WM. Nutritional and medicinal value of specialty mushrooms. Journal of Food Protection. 1990;53(10):883894.
40. Camilleri E, Blundell R, Baral B. Unveiling the full spectrum of maitake mushrooms: A comprehensive review of their medicinal, therapeutic, nutraceutical, and cosmetic potential. Heliyon. 2024;10(9):e30254.
41. Chang ST. Mushroom biology and mushroom products. The Chinese University Press, Hong Kong; 1991.
42. Chang ST. Mushroom research and developmentEquality and mutual benefit. Mushroom Biology and Mushroom Products. 1996;1:1-10.
43. Chang ST. Global impact of edible and medicinal mushrooms on human welfare. International Journal of Medicinal Mushrooms. 1999;1(1):1-7.
44. Chang ST. The world mushroom industry: Trends and technological development. International Journal of Medicinal Mushrooms. 2006;8(4):297-314.
45. Chang ST, Buswell JA. Mushroom nutriceuticals. World Journal of Microbiology and Biotechnology. 1996;12:473-476.
46. Chang ST, Miles PG. Edible Mushrooms and Their Cultivation. Boca Raton, FL: CRC Press; 1989.
47. Chang ST, Wasser SP. The role of culinary-medicinal mushrooms in human welfare. International Journal of Medicinal Mushrooms. 2012;14(2):95-134.
48. Cheung PCK. The nutritional and health benefits of mushrooms. Nutrition Bulletin. 2010;35(4):292-299.
49. Cheung PCK. Mini-review on edible mushrooms as functional foods. Food Science and Human Wellness. 2021;10(3):289-295.
50. Cui J, Chisti Y, Poloni V. Medicinal mushrooms and their therapeutic applications. Biotechnology Advances. 2021;49:107763.
51. Das A, Sharma VP, Singh M. Recent developments in mushroom cultivation technology in India. Mushroom Research. 2022;31(2):95-112.
52. Das K, Mukherjee A. Wild edible mushrooms of India. Indian Journal of Traditional Knowledge. 2007;6(1):7280.
53. De Silva DD, Rapior S, Hyde KD, Bahkali AH. Medicinal mushrooms in human health: Past, present and future. Fungal Diversity. 2021;111:1-29.
54. Deepalakshmi K, Mirunalini S. Therapeutic properties and current medical usage of medicinal mushrooms. International Journal of Pharmaceutical Sciences Review and Research. 2014;24(1):193-199.
55. Devi R, Singh R. Post-harvest management and value addition of edible mushrooms. Indian Horticulture. 2021;66(5):22-28.
56. Elkhateeb WA, Daba GM, Thomas PW, Wen TC. Medicinal mushrooms as a source of bioactive metabolites. Journal of Fungi. 2020;6(4):300.
57. Erjavec J, Kos J, Ravnikar M, Dreo T, Sabotič J. Proteins of higher fungi-From forest to application. Trends in Biotechnology. 2012;30(5):259-273.
58. Ferreira ICFR, Barros L, Abreu RMV. Antioxidants in wild mushrooms. Current Medicinal Chemistry. 2009;16(12):1543-1560.
59. Ferreira ICFR, Heleno SA, Barros L. Mushrooms as sources of natural antioxidants. Antioxidants. 2021;10(11):1732.
60. Finimundy TC, Dillon AJP, Henriques JAP, Ely MR. Medicinal mushrooms as functional foods. Food Chemistry. 2013;141(3):2666-2672.
61. Gasecka M, Magdziak Z, Siwulski M, Mleczek M. Bioactive compounds in edible and medicinal mushrooms. Molecules. 2022;27:3215.
62. Ghosh S, Bisaria R. Biotechnology of mushrooms. Current Science. 2002;82(8):989-996.
63. Ghosh S, Bisaria R. Mushroom biotechnology for sustainable agriculture. Biotechnology Reports. 2020;28:e00515.
64. Grimm D, Wösten HAB. Circular economy approaches in mushroom cultivation. Applied Microbiology and Biotechnology. 2021;105:5135-5148.
65. Gupta M, Gupta S, Annepu SK. Advances in mushroom production technologies. Current Agriculture Research Journal. 2022;10(1):1-15.
66. Gupta S, Summuna B, Gupta M, Annepu SK. Edible mushrooms: Cultivation, bioactive molecules, and health benefits. Biotechnology Reports. 2021;31:e00619.
67. Heleno SA, Barros L, Martins A, Morales P, FernándezRuiz V, Glamoclija J, et al. Nutritional value and bioactive compounds of mushrooms. Food Research International. 2020;137:109577.
68. Heleno SA, Martins A, Queiroz MJRP, Ferreira ICFR. Bioactivity of phenolic acids from mushrooms. Food Chemistry. 2015;173:501-513.
69. Hobbs C. Medicinal Mushrooms: An Exploration of Tradition, Healing and Culture. Botanica Press; 1995.
70. Hobbs C. Medicinal Mushrooms: The Essential Guide (Updated ed.). Storey Publishing; 2021.
71. Hyde KD, Xu J, Rapior S, et al. The amazing potential of fungi: 50 ways we can exploit fungi industrially. Fungal Diversity. 2019;97:1-136.
72. Jonathan SG, Fasidi IO. Studies on nutrient composition of mushrooms. Food Chemistry. 2003;83(2):255-258.
73. Kalač P. A review of chemical composition and nutritional value of wildgrowing and cultivated mushrooms. Journal of the Science of Food and Agriculture. 2013;93(2):209-218.
74. Kalač P. Health-promoting compounds in edible mushrooms. Food Chemistry. 2021;353:129436.
75. Khan MA, Tania M. Bioactive compounds and therapeutic potential of Hericium erinaceus. Food Science and Human Wellness. 2020;9(3):231-242.
76. Khan MA, Tania M, Liu R, Rahman MM. Hericium erinaceus: Medicinal values and therapeutic applications. Food Reviews International. 2013;29(2):113-136.
77. Khatua S, Paul S, Acharya K. Mushroom biotechnology in India: Present status and future prospects. Journal of Applied Biology and Biotechnology. 2021;9(4):1-11.
78. Kidd PM. The use of mushroom glucans and proteoglycans in cancer treatment. Alternative Medicine Review. 2000;5(1):4-27.
79. Kumar K, Sharma VP, Singh M. Entrepreneurship opportunities in mushroom cultivation. Mushroom Research. 2022;31(1):1-10.
80. Lindequist U, Niedermeyer THJ, Jülich WD. The pharmacological potential of mushrooms. Evidence-Based Complementary and Alternative Medicine. 2005;2(3):285-299.
81. Liu Y, Pang X, Wang X, Lv J. Bioactive polysaccharides from medicinal mushrooms. International Journal of Biological Macromolecules. 2021;183:1306-1321.
82. Liu Y, Wang X, Pang X, Mu X, Lv J. Recent advances in medicinal mushroom research. Critical Reviews in Food Science and Nutrition. 2019;59(13):2145-2161.
83. Łysakowska P, Sobota A, Wirkijowska A. Medicinal mushrooms: Their bioactive components, nutritional value and application in functional food production -A review. Molecules. 2023;28(14):5393.
84. Manzi P, Aguzzi A, Pizzoferrato L. Mushroom-based functional foods and nutraceuticals. Foods. 2021;10(6):1235.
85. Manzi P, Gambelli L, Marconi S, Vivanti V, Pizzoferrato L. Nutrients in edible mushrooms. Food Chemistry. 1999;65(4):477-482.
86. Martínez-Medina A, et al. Sustainable fungal biotechnology for agriculture and food production. Trends in Biotechnology. 2022;40(8):947-961.
87. Miles PG, Chang ST. Mushrooms: Cultivation, Nutritional Value, Medicinal Effect, and Environmental Impact. CRC Press; 2004.
88. Money NP. The Lives of Fungi (2nd ed.). Princeton University Press; 2021.
89. Muszyńska B, Kała K, Rojowski J, GrzywaczKisielewska A, Opoka W, Sułkowska-Ziaja K. Medicinal properties of mushrooms. Journal of Traditional and Complementary Medicine. 2021;11(3):199-209.
90. Nawaz A, Ahmad M, Khan S. Functional foods based on medicinal mushrooms: Recent progress. Foods. 2023;12:2897.
91. Patel S. Mushroom-derived nutraceuticals: Future perspectives. Critical Reviews in Food Science and Nutrition. 2021;61(17):2864-2880.
92. Rahi DK, Malik D, Kumar A. Advances in spawn production technology. Mushroom Research. 2022;31(2):113-126.
93. Reis FS, Martins A, Barros L, Ferreira ICFR. Antioxidant properties of medicinal mushrooms. Food and Chemical Toxicology. 2012;50(5):1201-1210.
94. Royse DJ. A global perspective on the high five: Agaricus, Pleurotus, Lentinula, Auricularia, and Flammulina. Proceedings of the 8th International Conference on Mushroom Biology and Mushroom Products. 2014:1-6.
95. Royse DJ. Mushroom production systems: Recent advances and future challenges. Journal of Fungi. 2021;7:1003.
96. Royse DJ, Beelman RB. Mushroom cultivation and human health. Annual Review of Food Science and Technology. 2022;13:379-401.
97. Sánchez C. Modern aspects of mushroom culture technology. Applied Microbiology and Biotechnology. 2004;64(6):756-762.
98. Sánchez C. Biotechnology of edible and medicinal mushrooms. Applied Microbiology and Biotechnology. 2021;105:7803-7821.
99. Sharma VP, Annepu SK, Gautam Y, Singh M, Kamal S. Status of mushroom production in India. Mushroom Research. 2017;26(2):111-120.
100. Sharma VP, Kumar S, Annepu SK. Commercial cultivation technologies for specialty mushrooms in India. Mushroom Research. 2023;32(1):1-18.
101. Singh M, Vijay B, Kamal S, Wakchaure GC. Mushroom Cultivation in India. ICAR-Directorate of Mushroom Research. 2021.
102. Tuli HS, Sharma AK, Sandhu SS, Kashyap D. Medicinal mushrooms: A review of bioactive compounds and therapeutic potential. Biomedicine & Pharmacotherapy. 2022;149:112901.
103. Valverde ME, Hernández-Pérez T, Paredes-López O. Edible mushrooms: Improving human health and promoting quality life. International Journal of Microbiology. 2021:Article ID 376387.
104. Venturella G, Ferraro V, Cirlincione F, Gargano ML. Medicinal mushrooms: Bioactive compounds and biological activities. Plant Biosystems. 2021;155(3):472481.
105. Wasser SP. Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides. Applied Microbiology and Biotechnology. 2002;60(3):258-274.
106. Wasser SP. Medicinal mushroom science: Current perspectives, advances, evidences, and challenges. Biomedical Journal. 2014;37(6):345-356.
107. Wasser SP. Medicinal mushrooms in integrative medicine. International Journal of Medicinal Mushrooms. 2021;23(10):1-18.
108. Wu F, Zhou LW, Yang ZL, Bau T, Li TH, Dai YC. Resource diversity of Chinese macrofungi and their utilization. Mycology. 2019;10(4):220-233.
109. Yang W, Guo F, Wan Z. Advances in extraction technologies for mushroom polysaccharides. International Journal of Biological Macromolecules. 2022;209:11241138.
110. Zhang J, Yu Y, Zhang X, Zhao Y. Bioactive compounds, pharmacological activities, and industrial applications of medicinal mushrooms: A comprehensive review. Foods. 2023;12(18):3412.
111. Zhang Y, Geng W, Shen Y, Wang Y, Dai YC. Edible mushroom cultivation for sustainable agriculture and food security. Journal of Fungi. 2022;8:1234.
112. Zied DC, Pardo-Giménez A. Edible and Medicinal Mushrooms: Technology and Applications. WileyBlackwell; 2017.